Ads
related to: macular degeneration medications to avoid drugs examples names
Search results
Results from the WOW.Com Content Network
Macular degeneration is an incurable eye condition that affects the retina. It comes in two forms: wet and dry. Generally, medications can help with age-related macular degeneration, or AMD.
Anti–vascular endothelial growth factor therapy, also known as anti-VEGF (/ v ɛ dʒ ˈ ɛ f /) therapy or medication, is the use of medications that block vascular endothelial growth factor. This is done in the treatment of certain cancers and in age-related macular degeneration .
Bevacizumab has been used against wet age-related macular degeneration, as well as macular edema from diseases such as diabetic retinopathy and central retinal vein occlusion. [2] Buprenorphine has been shown experimentally (1982–1995) to be effective against severe, refractory depression. [3] [4]
The incidence of age-related macular degeneration and its associated features increases with age and is low in people <55 years of age. [101] Smoking is the strongest modifiable risk factor. [102] As of 2008, age-related macular degeneration accounts for more than 54% of all vision loss in the white population in the US. [103]
The FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work the same way as Eylea which prevents abnormal blood vessel growth in the eye and helps preserve ...
In addition to their use as anti-cancer drugs, angiogenesis inhibitors are being investigated for their use as anti-obesity agents, as blood vessels in adipose tissue never fully mature, and are thus destroyed by angiogenesis inhibitors. [35] Angiogenesis inhibitors are also used as treatment for the wet form of macular degeneration.
Aflibercept, sold under the brand names Eylea and Zaltrap among others, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. [16] [17] It was developed by Regeneron Pharmaceuticals. It is an inhibitor of vascular endothelial growth factor (VEGF).
Wet macular degeneration and macular oedema (including diabetic macular oedema) Haemorrhage (conjunctival, vitreous and injection site), increased intraocular pressure, vitreous detachment and retinal degeneration. None---D: C: 10 August 2012: 22 January 2007: 27 February 2007 Regorafenib: Bayer: RET, VEGFR, PDGFR
Ads
related to: macular degeneration medications to avoid drugs examples names